One of Louisville’s largest manufacturing firms acquires Arizona company

Related Posts

04Oct

Siamab Therapeutics Presents New Data at AACR’s Ovarian Cancer Conference Demonstrating its Anti-STn Antibody Therapeutics Inhibit Tumor Growth in Ovarian Cancer Models

Siamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer immunotherapies, today announced the presentation of new preclinical data for its... read more
05Jun

KnipBio makes progress with new sustainable aquafeed

US fish feed developer KnipBio has extended its pipeline by taking its KBM324 product candidate through the pre-commercialization stage. Read... read more
17Jan

Myomo to Present at Noble Capital Markets’ 14th Annual Investor Conference

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that it will... read more
05Feb

RevBio Enters the Animal Health Market to Help Improve Canine Dental Care

As its first veterinary application, RevBio, Inc. announced that it has initiated a clinical study to validate the use of... read more
17Sep

FYZICAL Therapy and Balance Centers El Paso Brings New Technology to its Clinics to Support Patients Faced With Knee Pain

FYZICAL Therapy and Balance Centers – El Paso, announces today the launch of KneeKGTM into all four of their locations.... read more
13Jun

Entrepreneur sells house to fund biz, later secures millions from investors

EcoSoul Home Inc, which has recently secured $10 million - Series A round led by Accel and Singh Capital Partners,... read more
29Jun

Why Partnering Is The Key To Innovative Engineering Software

A Product Lifecycle Management (PLM) software company, Aras Corporation, tapped AMC Bridge to help develop a modern visualization tool for... read more
12Nov

Corbus Pharmaceuticals Updates Data from Lenabasum Open-Label Extension Studies in Systemic Sclerosis and Dermatomyositis at 2019 ACR Annual Meeting

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced continued... read more
28Jul

Silo Pharma’s partner, Zylo Therapeutics, yielded positive results in reducing neuropathic nerve pain in a small animal study.

Silo Pharma, Inc., a development-stage biopharmaceutical company today announced that its topically administered Ketamine reached a positive end point in... read more
06Mar

Bottom Line

The business software company FutureFuel.io hired Jim Gould Strategies to lobby for legislation that creates tax incentives for employers to... read more